12 Result(s)

Article

Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis)

The introduction of biological therapies has revolutionized the treatment of moderate-to-severe plaque psoriasis. In particular, ixekizumab, an inhibitor of interleukin-17A, has shown great results in terms of...

Mario Valenti, Luigi Gargiulo, Luciano Ibba… in Dermatology and Therapy (2024)

Article

OPT-In; Optimized Patient Treatment Outcomes in Plaque Psoriasis: A 3-Year State-Transition Treatment-Sequencing Model in the Italian Setting

There are several treatment options for plaque psoriasis (PsO), but uncertainty remains around the optimal sequencing of treatments. The aims of this study were to investigate how adopting a best-treatment-fir...

Sarah Alulis, Nicoletta Bernardini, Martina Burlando… in Dermatology and Therapy (2024)

Article

Commentary: Unmet Needs in Generalized Pustular Psoriasis in Clinical Practice

Anna Balato, Francesca Ambrogio, Martina Burlando… in Dermatology and Therapy (2024)

Article

Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study

There is limited evidence to guide clinicians on the treatment of psoriasis with biologics in patients with a history of malignancy who are often excluded from clinical trials investigating biologics. The aim ...

Cristina Pellegrini, Maria Esposito, Ernesto Rossi… in Dermatology and Therapy (2022)

Article

Impact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study

The efficacy of biological therapies used for the treatment of chronic plaque psoriasis can be influenced by numerous variables including  body mass index (BMI).

Federico Pirro, Giacomo Caldarola, Andrea Chiricozzi… in Clinical Drug Investigation (2021)

Article

A real-world economic analysis of biologic therapies for moderate-to-severe plaque psoriasis in Italy: results of the CANOVA observational longitudinal study

Psoriasis is a chronic immune-mediated inflammatory skin disease which can also involve joints. It is often associated with burdensome comorbidities which negatively impact prognosis and quality of life (QoL)....

Emanuela Zagni, Luca Bianchi, Gabriella Fabbrocini… in BMC Health Services Research (2021)

Article

PSOdisk is a reliable, intuitive instrument for the evaluation of psychological distress, which strongly correlates with DLQI: a preliminary study

PSOdisk is a 10-item visual instrument, aimed at assessing the burden of disease in patients with psoriasis.

Emanuele Cozzani, Dennis Linder, Martina Burlando… in European Journal of Dermatology (2018)